Prakash Investment Advisors LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 2,301 shares of the medical equipment provider's stock, valued at approximately $1,201,000. Intuitive Surgical accounts for approximately 1.2% of Prakash Investment Advisors LLC's investment portfolio, making the stock its 16th biggest position.
Other large investors have also recently made changes to their positions in the company. State Street Corp increased its stake in shares of Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock worth $7,393,673,000 after purchasing an additional 210,363 shares during the last quarter. FMR LLC grew its holdings in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the period. Geode Capital Management LLC increased its position in Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider's stock worth $3,677,194,000 after buying an additional 143,440 shares during the last quarter. Fisher Asset Management LLC raised its stake in shares of Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider's stock valued at $2,349,441,000 after buying an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. lifted its position in shares of Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider's stock valued at $1,890,676,000 after buying an additional 24,183 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several equities research analysts recently weighed in on the company. Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Piper Sandler reiterated an "overweight" rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. UBS Group raised their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a report on Monday, January 27th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.
View Our Latest Research Report on ISRG
Insiders Place Their Bets
In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 108 shares of the business's stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,348 shares of company stock valued at $3,587,582 in the last ninety days. Company insiders own 0.90% of the company's stock.
Intuitive Surgical Stock Up 0.3 %
Shares of NASDAQ ISRG traded up $1.84 during midday trading on Monday, reaching $593.63. The company had a trading volume of 653,802 shares, compared to its average volume of 1,693,389. The stock has a market cap of $211.44 billion, a PE ratio of 92.53, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The firm's fifty day moving average price is $565.45 and its 200-day moving average price is $525.60.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.